Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases
Document Type
Letter to the EditorPublication Date
2013-02-01Keywords
Biomedical ResearchGenetic Therapy
Genomics
Humans
International Cooperation
UMCCTS funding
Genetics and Genomics
Therapeutics
Metadata
Show full item recordSource
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, Boycott K, Braun S, Breakefield XO, Bueren JA, Buschmann M, Byrne BJ, Calos M, Cathomen T, Chamberlain J, Chuah M, Cornetta K, Davies KE, Dickson JG, Duchateau P, Flotte TR, Gaudet D, Gersbach CA, Gilbert R, Glorioso J, Herzog RW, High KA, Huang W, Huard J, Joung JK, Liu D, Liu D, Lochmüller H, Lustig L, Martens J, Massie B, Mavilio F, Mendell JR, Nathwani A, Ponder K, Porteus M, Puymirat J, Samulski J, Takeda S, Thrasher A, VandenDriessche T, Wei Y, Wilson JM, Wilton SD, Wolfe JH, Gao G. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther. 2013 Feb;21(2):266-8. doi:10.1038/mt.2013.4. Link to article on publisher's siteDOI
10.1038/mt.2013.4Permanent Link to this Item
http://hdl.handle.net/20.500.14038/30120PubMed ID
23369965Notes
Full author list omitted for brevity. For the full list of authors, see article.
Related Resources
Link to Article in PubMedRights
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.ae974a485f413a2113503eed53cd6c53
10.1038/mt.2013.4